John Wilkerson , 2025-04-17 23:09:00
WASHINGTON — The Food and Drug Administration will remove industry representatives from advisory committees and replace them with patients and caregivers, Commissioner Marty Makary announced Thursday.
While that’s not really a big change, it’s the latest effort by Makary and his boss, HHS Secretary Robert F. Kennedy Jr., to reduce the influence of the pharmaceutical industry.
Makary announced the change during his first interview as commissioner. He spent much of the conversation with Megyn Kelly lambasting his agency for its ties to industry. Makary told Kelly that he was shocked to learn that drug industry representatives are allowed to sit on FDA advisory committees.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.